Capture
PRODUCTS
-
With over 130 in-life gene therapy studies completed, Altasciences is a leading expert in gene therapy research, with integrated preclinical and bioanalytical capabilities.
-
Capture data at the true source: the patient. Improve the patient experience with secure, accessible questionnaires both via email and through the Castor Connect mobile application.
-
Controlled by software designed to meet 21 CFR Part 11 regulatory standards, Prometheus Panta C facilitates data integrity through distinct user access groups, while Active Directory integration provides centralized user authentication. Features such as electronic signatures, electronic records, and comprehensive audit trails further strengthen regulatory alignment.
-
Germfree’s compliant modular compounding pharmacies offers non-hazardous and hazardous drug compounding within our established modular platform. It enables hospital pharmacies to manage surges, maintain patient support during renovations, and enhance efficiency with Germfree’s cutting-edge modular hospital compounding pharmacy.
-
Transform your optical systems with Semrock filters - the brightest, most durable, and spectrally sophisticated filters in the market.
WHITE PAPERS AND CASE STUDIES
-
Streamline Analytical Tech Transfer Through Analytical Target Profile
Analytics debt in CGT can derail timelines and budgets. Learn how early ATP planning and cross-functional alignment can eliminate costly setbacks and accelerate IND approvals.
-
Advancing Drug Development With Optimized LC-MS/MS Bioanalysis
Explore the critical role of sample preparation optimization and the application of liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) in bioanalytical method development.
-
Modernizing Operational Maintenance At Treatment Plants
In 2017, the Harford County Division of Water and Sewer began looking for a modern work management solution to help automate preventive maintenance, coordinate work activities between groups, manage material inventories, and capture important data.
-
Preclinical Evaluation Of New Antifibrotics In NASH-Induced Fibrosis Models
Accelerate the development of antifibrotic therapies through our clinically relevant models, deep scientific expertise, and proven preclinical capabilities in this area of unmet medical need.
-
Isolate Bright GFP-Expressing HEK293 Cells For Cell Line Development Workflow
Explore a high-efficiency workflow for isolating and expanding GFP-expressing HEK293 cells that enables stable, bright clones ideal for imaging and tracking to simplify clonal development.
-
UV Disinfection And Dechlorination At Cottonseed Processing Facility In Texas, US
The Archer Daniels Midland Company (ADM) requires full-scale nonchemical disinfection and dechlorination treatment of RO feedwater to the boiler which supports their cottonseed processing facility in Lubbock, Texas.
-
Collaborate With Sponsors, Ensure Compliance, And Secure Product Quality
A top 5 global CDMO implemented cloud-based IDBS PIMS for improved manufacturing data collection and information visibility for real-time decision-making.
-
Delivering A Registrational GI Trial Through Ongoing Protocol Shifts
A biotech developing bispecific antibodies partnered with a flexible CRO to launch its first U.S. GI oncology trial, requiring strategic insight and full-service clinical support.
-
Microbial Challenge In-Use Studies
Learn more about how a partner with expertise can help you navigate the complex landscape of microbial challenge in-use studies and ensure the highest standards of patient care.
-
Handle Single-Use Technology Biopharma Waste: Data Sharing, Collaboration
Learn more about data sharing and collaboration to enable a better environmental impact of single-use technologies (SUTs) and quantifying the single-use plastic waste generated when manufacturing mAbs.
-
Criticality And Risk Analysis Helps Mojave Water Agency Optimize Maintenance Activities And Realize Cost Savings
Amid a decrease in water supply and reliability, the MWA has seen a rise in costs and operational challenges related to regional expansion, increased regulatory requirements, climate change, and aging infrastructures. Despite these challenges, the MWA remains committed to managing groundwater basins sustainably, importing water responsibly, and proactively addressing risks using sound scientific practices.
-
Flexible Fill/Finish Solutions To Bridge The Clinical-To-Commercial Gap
As biopharma complexity grows, flexible CDMOs are essential for navigating evolving fill/finish needs, accelerated timelines, and regulatory uncertainty with agility and expertise.
NEWS
-
Cost-Efficient And Proven Solution For Sample Testing10/9/2025
Developed to meet the highest standards in sample integrity, Micronic’s Non-Coded and Alphanumeric Coded tubes provide laboratories worldwide with reliable, durable, and contamination-free solutions for accurate testing.
-
Harnessing Supercomputing Power For Drug Discovery7/14/2025
A collaboration between the University of Miami’s Frost Institute for Data Science and Computing and a precision medicine company has proven that using powerful supercomputers can speed early-stage drug research.
-
Alphatechs USA Presents Innovative School Cafeteria Scanners At SNA ANC 20257/8/2025
Alphatechs USA is proud to present its line of innovative school lunch scanners for K12 cafeterias at SNA ANC 2025 in San Antonio. TX.
-
Lunartap Introduces Detailed Digital Solutions To Support Business Communication And Engagement6/30/2025
Lunartap, a digital services platform has introduced a growing collection of tools designed to enhance digital engagement and smoothen contactless communication.
-
Bionano Laboratories Announces A Second Category I CPT Code For OGM Established By The AMA; This One For Use In Whole Genome Analysis For Constitutional Genetic Disorders5/19/2025
Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed tests (LDTs) based on optical genome mapping (OGM), today announced that the editorial panel of the American Medical Association (AMA) established a new Category I Current Procedural Terminology (CPT®) code for the use of OGM in cytogenomic genome-wide analysis to detect structural and copy number variations related to constitutional genetic disorders.